Clinical trial
Balance4Mobility: Effects of Walkasins Use on Clinical Outcomes of Gait and Balance Function in Individuals With Peripheral Neuropathy and Balance Problems - A Randomized Control Trial
NCT06959277 is registered in ClinicalTrials.gov with RxFunction Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Balance4Mobility: Effects of Walkasins Use on Clinical Outcomes of Gait and Balance Function in Individuals With Peripheral Neuropathy and Balance Problems - A Randomized Control Trial
- Lead sponsor
- RxFunction Inc.
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- June 17, 2025
- Completion date
- June 30, 2028
- Enrollment
- 200 (estimated)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
balance control in elderly, gait disorders, peripheral neuropathies, peripheral neuropathy due to chemotherapy, peripheral neuropathy with type 2 diabetes